HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Targeted therapies revolutionize cancer treatment by precisely targeting specific molecules or pathways crucial for cancer cell growth and survival. In contrast to conventional chemotherapy's indiscriminate impact on rapidly dividing cells, targeted therapies focus on unique cancer cell features, often driven by genetic mutations or abnormal proteins. This precision results in more effective treatment with fewer side effects, marking a significant advancement in oncology.
Monoclonal antibodies, a key category of targeted therapies, mimic the immune system's ability to identify and neutralize specific cells. Small molecule inhibitors are another approach, disrupting signaling pathways vital for cancer cell proliferation. The success of targeted therapies spans various cancer types, highlighting their potential to customize treatments based on each patient's cancer molecular profile. Ongoing research into cancer biology promises the development of novel, even more precise targeted therapies, shaping the future of personalized cancer care.
